Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients

Clinical trial pipeline · Data from ClinicalTrials.gov

See which Evaluate the Effectiveness of CMV Prevention Strategies in Kidney Transplant Recipients trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

All recent trials (1 shown)

Not Yet RecruitingPhase 4

NCT07203664

Use of Tacrolimus and MTOR Inhibitors With Anticipatory Therapy vs. Tacrolimus and Mycophenolic Acid With Universal Prop…

The overall objective of this project is to optimise preventive treatment of CMV infection/disease in renal transplant recipients at increased risk of CMV post-…

Spain30 participantsStarted 2025-10-30

Treatment: steroids, tacrolimus and mTOR inhibitors, steroids, tacrolimus and mycophenolic acid.